Navigation Links
Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
Date:12/22/2010

NEW YORK, Dec. 22, 2010 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.

"Our team has achieved a significant milestone with the filing of our NDA," said Eamonn P. Hobbs, CEO & President of Delcath Systems. "We believe that our application is comprehensive and complete, and we are optimistic that it will be accepted for review by the FDA. Considering the limitations of current treatment options, we believe the chemosaturation system can offer hope to patients with metastatic melanoma in the liver. We have requested priority review of our NDA by the FDA, which if granted could result in a 6-month review of the application.  Priority review is granted by the FDA to those products that address significant unmet medical needs or have the potential to provide significant improvement compared to marketed products. With the strength of our Phase III data, we believe that our application meets the FDA's criteria for priority review."

The FDA normally requires 60 days to perform a cursory review and assess whether the NDA is sufficiently complete to warrant a substantive review and issue a Prescription Drug User Fee Act (PDUFA) action date. Delcath intends to make further announcements as the review proceeds, including the FDA's response to the application and potential determination of a PDUFA action date.

About Delcath Systems
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015  The quality function within the ... products meet quality standards at every stage of the ... quality leaders also have the challenge of balancing quality ... Those who don,t effectively balance these priorities risk funding ... marketplace failure and regulatory scrutiny. For the ...
(Date:3/27/2015)... , March 27, 2015 Object recognition technology ... visually impaired and elderly. The VelaSense ® ... to lead more independent, productive and fulfilling lives. VelaSense ... will allow users to identify objects from a one ... as create customized object databases for personal use. ...
(Date:3/27/2015)... - Russell Williams , President of ... 2015-2016 Quebec Budget, noting the fiscal discipline and the ... However, the association is concerned about the decline of ... intent to strive for a balanced budget this year, ... Quebec,s economic development is encouraging," said Mr. ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2VelaSense Object Recognition Technology for the Blind was unveiled at Baruch College's CCVIP 8th Annual Conference 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3
... Inc. (OTC Bulletin Board: NEPH ), a ... therapeutic applications, infection control, and water purification, today announced ... previously announced rights offering to its existing stockholders was ... and Exchange Commission. Under the terms of ...
... 2011 Associates of Cape Cod, Inc., (ACC) ... DETECTION SYSTEM incorporating the enhanced Pyrochrome® chromogenic reagent ... tube reader. This system offers our customers diverse ... ACC,s enhanced Pyrochrome® is a versatile, quantitative reagent ...
Cached Medicine Technology:Nephros Rights Offering Registration Statement Declared Effective 2Nephros Rights Offering Registration Statement Declared Effective 3Nephros Rights Offering Registration Statement Declared Effective 4New Chromogenic Endotoxin Detection System 2
(Date:3/27/2015)... Operatic contenders and their avid audience will be ... universally acclaimed baritone Sherrill Milnes will be overseeing the ... The Merion in Evanston. The event is the culmination ... singers from around the country. “This is a highly-anticipated ... talent in the country,” said Margaret Gergen, executive director ...
(Date:3/27/2015)... 2015 Approximately 300 advocates participated ... Coalition Lobby Day to lobby for physical education, ... (SHIP). Everlast Climbing was especially interested in ... which would strengthen physical education programs by adopting ... other measures to strengthen physical education in schools. ...
(Date:3/27/2015)... 2015 Airy Jeanine is a rising ... music video for her debut song “Mama’s Girl”, launched ... and abstract styling effects, the thematic video for the ... Vimeo, and assorted outlets. It will be integral in ... expanding full-scale marketing strategy. The video promotion campaign spearheaded ...
(Date:3/27/2015)... Newport, RI (PRWEB) March 27, 2015 April ... civil war – the Sesquicentennial. To honor America’s bloodiest war ... the Fort Adams Trust presents A Tribute to the Civil ... 7:00 PM, Friday, April 17, 2015, at the Jane Pickens ... Williams, noted Civil War-Lincoln scholar, will serve as the master ...
(Date:3/27/2015)... March 27, 2015 The Florida Center ... Brain Cancer Cure (ABC2), awarded $350,000 to support brain ... Florida, The Scripps Research Institute and H. Lee Moffitt ... studies with a clear development path and potential to ... the near future. , The awards fund research ...
Breaking Medicine News(10 mins):Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3
... say that they have developed a faster, less expensive ... stretches of DNA. The development of the new technique ... mutant genes, but also from mutations of other DNA ... occur as a consequence of deleting non-gene DNA sequences, ...
... is an eye disease that can cause blindness and ... get past the blood-brain barrier making it an ... an engineering professor with appointments in UCFs Advanced Materials ... ,Seal and his colleagues from North Dakota ...
... suggests that playing with candy cigarettes may favorably set ... smokers . , The study, reported in ... a nationally representative sample of 25,887 US adults, the ... in current and former smokers vs. 22% in never ...
... Kingdom have found that patients with COPD, or chronic ... researchers also found that those COPD patients with osteoporosis, ... greater arterial stiffness. These premature signs of aging may ... cardiovascular disease. ,Their research results appear in ...
... Cancer Center researchers helps explain how memory T cells ... shows lymph nodes are not just organs where immune ... where a major fight against the spread of an ... many viruses, the body becomes immune (protected) from recurrence ...
... pair and played hide-and-seek Monday evening in a relatively rare ... ,As the cloud blanket gave way to an ... fields, parks and from top of their houses - had ... of the Nehru Planetarium here, assisted by over a dozen ...
Cached Medicine News:Health News:Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA 2Health News:Nanoparticle in the Treatment of Glaucoma 2Health News:The Danger in Candy Cigarettes 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 3Health News:Memory T Cells Protect the Body from Viruses 2
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
200 L, Bulk, clear Recommended for 20, 25, 50, 100 and 200 L pipettes. ...
Its generous filter placement, MicroPoint design, and reference marks at 10, 50, and 100 ul make this ART tip ideal for many 200 ul pipettors....
... tips, microfuge tubes and PCR tubes. ... RNase- and DNase-free. Tubes have a ... 120°C. Available in a variety of ... a low binding surface. PCR Tubes ...
Medicine Products: